Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05624905

Prospective Pecutaneous Coronary Intervention Registry

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Percutaneous Coronary Intervention Vascular Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.

Exclusion criteria

  • patients who did not consent to the research

Treatment and study plan

Percutaneous coronary intervention

Procedure

Percutaneous Coronary Intervention Procedure

Primary outcomes

  1. Rates of Cardiac death or Target-vessel myocardial infarction

    Time frame: up to 10 years

    A composite of cardiac death or target vessel myocardial infarction

  2. Rates of Major adverse cardiac and cerebrovascular event

    Time frame: up to 10 years

    A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization

Secondary outcomes

  1. Rates of all-cause death

    Time frame: up to 10 years

    Death from any cause

  2. Rates of cardiac death

    Time frame: up to 10 years

    Death from cardiac cause

  3. Rates of myocardial infarction

    Time frame: up to 10 years

    Any myocardial infarction

  4. Rates of target-vessel myocardial infarction

    Time frame: up to 10 years

    target-vessel myocardial infarction

  5. Rates of target lesion revascularization

    Time frame: up to 10 years

    target lesion revascularization

  6. Rates of target vessel revascularization

    Time frame: up to 10 years

    target vessel revascularization

  7. Rates of cerebrovascular accident

    Time frame: up to 10 years

    ischemic or hemorrhagic stroke

  8. Rates of stent thrombosis

    Time frame: up to 10 years

    definite or probable stent thrombosis

Study contacts

Contact information is provided by the study sponsor or research team.

Joo-Yong Hahn, MD

CONTACT

[email protected]

82-2-3410-3419

Ki Hong Choi, MD

CONTACT

[email protected]

82-2-3410-6653

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Official study title

Prospective Registry for Identifying Long-term Prognosis in Patients Who Underwent Coronary Angiography and Percutaneous Coronary Intervention for Coronary Artery Disease

Acronym: SMC-PCI

Important dates

Study start
2016
Primary completion
2030
Study completion
2030
First posted
Nov 22, 2022
Registry last updated
Aug 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.